Lineage Cell Therapeutics, Inc. Expected to Earn FY2024 Earnings of ($0.18) Per Share (NYSEAMERICAN:LCTX)
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) – Investment analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Lineage Cell Therapeutics in a research report issued to clients and investors on Monday, August 12th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of ($0.18) per share […]
More Stories
Walt Disney (NYSE:DIS) Price Target Raised to $130.00
Walt Disney (NYSE:DIS – Free Report) had its price target increased by Guggenheim from $110.00 to $130.00 in a report...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Short Interest Update
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) saw a significant growth in short interest during the month of October....
South Street Advisors LLC Trims Stock Position in RTX Co. (NYSE:RTX)
South Street Advisors LLC cut its stake in shares of RTX Co. (NYSE:RTX – Free Report) by 7.5% in the...
Kulicke and Soffa Industries (NASDAQ:KLIC) Raised to “Buy” at Needham & Company LLC
Needham & Company LLC upgraded shares of Kulicke and Soffa Industries (NASDAQ:KLIC – Free Report) from a hold rating to...
Maxwell Wealth Strategies Inc. Grows Position in Tesla, Inc. (NASDAQ:TSLA)
Maxwell Wealth Strategies Inc. lifted its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 580.1% in the...
9,068 Shares in Pfizer Inc. (NYSE:PFE) Bought by Turtle Creek Wealth Advisors LLC
Turtle Creek Wealth Advisors LLC bought a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the 3rd quarter,...